Natixis Advisors L.P. Lowers Stake in Integer Holdings Co. (NYSE:ITGR)

Natixis Advisors L.P. decreased its position in shares of Integer Holdings Co. (NYSE:ITGR - Free Report) by 29.4% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 39,030 shares of the medical equipment provider's stock after selling 16,245 shares during the quarter. Natixis Advisors L.P. owned about 0.12% of Integer worth $3,867,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of ITGR. Blue Trust Inc. increased its holdings in Integer by 483.3% in the fourth quarter. Blue Trust Inc. now owns 455 shares of the medical equipment provider's stock worth $45,000 after purchasing an additional 377 shares in the last quarter. Strs Ohio lifted its position in shares of Integer by 54.5% during the 4th quarter. Strs Ohio now owns 1,700 shares of the medical equipment provider's stock valued at $168,000 after acquiring an additional 600 shares during the period. Van ECK Associates Corp boosted its stake in Integer by 22.0% during the third quarter. Van ECK Associates Corp now owns 1,733 shares of the medical equipment provider's stock worth $136,000 after acquiring an additional 313 shares in the last quarter. Mackenzie Financial Corp acquired a new stake in Integer in the fourth quarter worth $204,000. Finally, Cerity Partners LLC bought a new stake in Integer in the fourth quarter valued at $208,000. Institutional investors and hedge funds own 99.29% of the company's stock.

Wall Street Analysts Forecast Growth

A number of research firms have recently issued reports on ITGR. Bank of America raised shares of Integer from a "neutral" rating to a "buy" rating and increased their price objective for the stock from $105.00 to $135.00 in a research report on Monday, April 15th. CL King initiated coverage on Integer in a report on Thursday, March 14th. They set a "buy" rating and a $137.00 price objective for the company. KeyCorp increased their target price on Integer from $123.00 to $139.00 and gave the stock an "overweight" rating in a report on Tuesday, April 9th. Finally, Benchmark reiterated a "buy" rating and set a $130.00 price objective on shares of Integer in a report on Friday. Two research analysts have rated the stock with a hold rating and four have given a buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and an average price target of $127.00.

Integer Stock Down 0.2 %

NYSE:ITGR traded down $0.26 during trading hours on Friday, hitting $113.97. 206,477 shares of the company traded hands, compared to its average volume of 474,529. The company has a quick ratio of 2.01, a current ratio of 3.32 and a debt-to-equity ratio of 0.76. The company has a market cap of $3.82 billion, a PE ratio of 39.44, a PEG ratio of 1.69 and a beta of 1.12. The firm's 50-day simple moving average is $114.78 and its 200-day simple moving average is $102.57. Integer Holdings Co. has a one year low of $69.40 and a one year high of $123.99.

Integer (NYSE:ITGR - Get Free Report) last released its quarterly earnings results on Thursday, April 25th. The medical equipment provider reported $1.14 earnings per share for the quarter, beating analysts' consensus estimates of $1.12 by $0.02. Integer had a net margin of 6.01% and a return on equity of 11.25%. The company had revenue of $414.80 million for the quarter, compared to analyst estimates of $412.78 million. During the same period last year, the firm earned $0.87 earnings per share. The firm's revenue was up 9.5% on a year-over-year basis. Equities analysts predict that Integer Holdings Co. will post 5.27 earnings per share for the current year.

Insiders Place Their Bets

In other Integer news, VP Tommy P. Thomas sold 1,500 shares of Integer stock in a transaction dated Tuesday, April 30th. The shares were sold at an average price of $114.00, for a total value of $171,000.00. Following the sale, the vice president now owns 2,813 shares of the company's stock, valued at $320,682. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In other Integer news, VP Tommy P. Thomas sold 1,500 shares of the stock in a transaction on Tuesday, April 30th. The stock was sold at an average price of $114.00, for a total transaction of $171,000.00. Following the completion of the transaction, the vice president now directly owns 2,813 shares of the company's stock, valued at $320,682. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, EVP John A. Harris sold 312 shares of the business's stock in a transaction on Tuesday, May 7th. The shares were sold at an average price of $113.00, for a total value of $35,256.00. Following the completion of the sale, the executive vice president now owns 1,157 shares in the company, valued at $130,741. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 6,812 shares of company stock valued at $771,956. Insiders own 2.00% of the company's stock.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.